WallStSmart
ADMA

ADMA Biologics Inc

NASDAQ: ADMA · HEALTHCARE · BIOTECHNOLOGY

$10.60
-2.75% today

Updated 2026-04-29

Market cap
$2.46B
P/E ratio
17.67
P/S ratio
4.83x
EPS (TTM)
$0.60
Dividend yield
52W range
$7 – $24
Volume
6.8M

ADMA Biologics Inc (ADMA) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-23.61M$-23.61M$-19.00M$-24.46M$-19676.00$-29000.00$-6.90M$-10.89M$-14.70M$-15.42M$-18.27M$-37.27M$-62.68M$-76.19M$-102.00M$-112.37M$-59.51M$8.80M$118.67M$50.40M
Capital expenditures$0.00$0.00$0.00$0.00$0.00$0.00$118853.00$196635.00$2.32M$26073.00$73410.00$2.68M$2.10M$3.81M$12.73M$13.51M$13.91M$4.98M$8.57M$22.57M
Depreciation
Stock-based comp$626787.00$888295.00$1.25M$1.71M$1.25M$1.56M$2.22M$2.65M$2.86M$3.49M$5.21M$6.19M$13.62M$20.03M
Free cash flow$-23.61M$-23.61M$-19.00M$-24.46M$-19676.00$-29000.00$-7.02M$-11.08M$-17.03M$-15.44M$-18.34M$-39.95M$-64.77M$-80.01M$-114.73M$-125.88M$-73.42M$3.82M$110.10M$27.82M
Investing cash flow
Financing cash flow
Dividends paid$3.91M$0.00$0.00$0.00$0.00$0.00$61598.00$2.90M
Share repurchases
Debt repayment
Net change in cash$12.45M$13.61M$-8.95M$-6.76M$-526092.00$38.69M$-21.85M$-2717.00$29.17M$-4.83M$35.43M